Study of the prevalence of neuropsychological deficits in patients recovered from COVID-19 associated with post-intensive care syndrome

  • Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Total publications:0 publications

Grant number: 20/07957-2

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2023
  • Funder

    Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Principal Investigator

    Antonio de Pádua Serafim
  • Research Location

    Brazil
  • Lead Research Institution

    Diretoria de Pós-Graduação e Pesquisa. Universidade Metodista de São Paulo (UMESP). Instituto Metodista de Ensino Superior (IMS). São Bernardo do Campo , SP, Brazil
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

It is estimated that approximately one third or more of ICU survivors develop continuous and persistent cognitive impairment. As for patients with acute respiratory syndromes such as Covid-19, the prevalence of persistent cognitive impairment is even higher and can reach 78% in 1 year and 25% in 6 years. The literature has treated this phase of post-intensive care syndrome from English Post-intensive care syndrome (PICS), which describes, impairment of psychological health (emotional and cognitive) and physical function of patients who required ICU care. The aim of this study is to evaluate neuropsychological aspects in patients recovered from COVID-19. Method: Observational study that will use a digital platform containing a brief questionnaire of sociodemographic data and information on Covid-19 contamination and a neuropsychological battery with measures of attention, memory and executive functions, in addition to depressive and anxious aspects. It is intended to evaluate a sample of more than 500 participants for the composition of three groups: Light, Moderate and Serious Symptoms (treated in the ICU). The results of this study are expected to provide a cognitive overview of the sample to support the development of neuropsychological rehabilitation programs for patients with Covid-19 cognitive sequelae. (AU)